Skip to content

Effects of intake of royal jelly in type 2 diabetic patients

Effects of intake of Royal Jelly on serum glucose, Insulin, Hb A1c, Apo- AI, Apo- B levels, insulin resistance & blood pressure in type 2 diabetic patients refferred to Endocrine and Metabolism Institue of Iran University of Medical Sciences

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138905102709N8
Enrollment
50
Registered
2010-12-01
Start date
2010-11-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DIABETES MELLITUS. Non-insulin-dependent diabetes mellitus

Interventions

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: confirmed diabetes type 2 based on physicians diagnosis, being volunteer or willingness to attend, no history of cardiovascular, liver or kidney diseases, not receiving insulin prior to 3 months before the trial, age between 20-65 years old, HbA1c 6-8%, no allergy to honey or its products, BMI between 20-30, duration of type 2 diabetes mellitus for 5 -10 years, no history of smoking and alcohol drinking Exclusion criteria: cholesterol >=240mg/dl, TG>=400mg/dl, incomplete consumption of royal jelly, creation of allergy during the study period, using of any kind of food supplements, pregnancy, lactation, using of oral contraceptive pills, changing medication dosage

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fast blood sugar. Timepoint: Before and after the intervention. Method of measurement: Enzymatic,Glucose oxidase.;Serum Insulin Level. Timepoint: Before and after the intervention. Method of measurement: fast serum insulin level,IRMA method.;HOMA-R. Timepoint: Before and after the intervention. Method of measurement: HOMA-IR=Glucose ? Insulin/405,Calculating.;HbA1c. Timepoint: Before and after the intervention. Method of measurement: fast HbA1c serum level,Chromatography.;APO-A1. Timepoint: Before and after the intervention. Method of measurement: fast APO-A1 serum level,Immunoturbidimetry.;APO-B. Timepoint: before and after intervention. Method of measurement: fast APO-B serum level,Immunoturbidimetry.;Blood pressure. Timepoint: at the baseline, at the middle and the end of the study. Method of measurement: blood pressure,sphygmomanometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Farzad Shidfar

Iran University of Medical Sciences

farzadshidfar@yahoo.com+98 21 8860 2218

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026